Sale!

Ofloxacin Otic Solution 0.3% [CEO] (Ofloxacin Otic Solution CEO® / オフロキサシン耳科用液0.3%「CEO」)

元の価格は JPY ¥1,500 でした。現在の価格は JPY ¥1,380 です。

Japanese New Quinolone Antibacterial Otic Preparation (Ofloxacin 0.3%). For otic instillation in otitis externa and otitis media. 5mL x 5 (plastic bottles). Mfd. by Seoria Pharma Co., Ltd., Japan.

Bulk deal
Quantity Discount Discounted price
5 - 9 8% JPY ¥1,380
10 - 19 12% JPY ¥1,320
20 + 18% JPY ¥1,230
SKU: OFL-03-OTC Category:

Description

Product Overview / 商品概要

Ofloxacin Otic Solution 0.3% [CEO] (オフロキサシン耳科用液0.3%「CEO」)
Generic: Ofloxacin / オフロキサシン
Therapeutic Category: New Quinolone Antibacterial Otic Preparation / ニューキノロン系抗菌耳科用製剤
Manufactured by: Seoria Pharma Co., Ltd. / セオリアファーマ株式会社

Composition & Specification / 組成・規格

Active Ingredient: Ofloxacin (JP) 3.0mg per 1mL / 1mL中 日局オフロキサシン 3.0mg
Additives: Sodium chloride, Benzalkonium chloride, Anhydrous sodium dihydrogen phosphate, Sodium hydrogen phosphate hydrate, pH adjuster / 塩化ナトリウム、ベンザルコニウム塩化物、無水リン酸二水素ナトリウム、リン酸水素ナトリウム水和物、pH調節剤
Appearance: Light yellow to pale yellow clear aqueous otic solution; pH 6.0–7.0; Osmotic pressure ratio 1.0–1.2 (relative to physiological saline)
外観: 微黄色〜淡黄色澄明の水性耳科用液、pH 6.0〜7.0、浸透圧比 1.0〜1.2(生理食塩液に対する比)

Indications / 効能効果

EN: Susceptible organisms: Staphylococcus spp., Streptococcus spp., Streptococcus pneumoniae, Proteus spp., Morganella morganii, Providencia spp., Haemophilus influenzae, Pseudomonas aeruginosa
Indications: Otitis externa, Otitis media
JA: 〈適応菌種〉本剤に感性のブドウ球菌属、レンサ球菌属、肺炎球菌、プロテウス属、モルガネラ・モルガニー、プロビデンシア属、インフルエンザ菌、緑膿菌
〈適応症〉外耳炎、中耳炎

Dosage and Administration / 用法用量

EN: Usually, for adults, instill 6–10 drops per ear, twice daily. After instillation, perform ear bath for approximately 10 minutes. The number of administrations may be adjusted according to symptoms. For children, the number of drops should be reduced as appropriate.
JA: 通常、成人に対して、1回6〜10滴を1日2回点耳する。点耳後は約10分間の耳浴を行う。なお、症状により適宜回数を増減する。小児に対しては、適宜滴数を減ずる。

Contraindications / 禁忌

EN: Patients with a history of hypersensitivity to any component of this product or to levofloxacin hydrate
JA: 本剤の成分又はレボフロキサシン水和物に対し過敏症の既往歴のある患者

Regulatory Information / 規制情報

Approval No.: 22900AMX00005
Sales Started: November 2009 / 2009年11月
Classification Code: 871329
Storage: Store at room temperature / 室温保存
Shelf Life: 3 years / 3年

Packaging / 包装

Main Package (for sale): 5mL x 5 (plastic bottles) / 5mL×5(プラスチック瓶)
Other Available Packages (by special order): 5mL x 5 (plastic bottles), 5mL x 10 (plastic bottles)

Full product insert (添付文書) is attached as a downloadable PDF. For detailed precautions, drug interactions, and safety information, please refer to the official package insert.

Additional information

重さ 0.15 kg

Reviews

There are no reviews yet.

Be the first to review “Ofloxacin Otic Solution 0.3% [CEO] (Ofloxacin Otic Solution CEO® / オフロキサシン耳科用液0.3%「CEO」)”

メールアドレスが公開されることはありません。 が付いている欄は必須項目です

Export from Japan — Ofloxacin Otic Solution 0.3% [CEO] (Ofloxacin Otic Solution CEO®

🏭 Supply & Origin

  • Country of Origin: Japan
  • Regulatory Standard: PMDA (Japan) / GMP Compliant
  • Pharmacopoeia: Japanese Pharmacopoeia (JP)
  • Supplier: Mate Co., Ltd. — Licensed Pharmaceutical Wholesaler (License No. B14309, Osaka)
  • Supply Capacity: Full-line sourcing through Japan's regulated distribution channels

🚚 Shipping & Trade Terms

  • Incoterms: FOB Kansai International Airport (KIX)
  • Shipping: Air freight via B/L or AWB
  • Payment: 100% T/T in advance
  • Lead Time: 2-4 weeks after payment confirmation
  • Available Regions: EU, LATAM, APAC, Middle East, Africa

Request a Quotation

For pricing, MOQ, and regulatory documentation, contact our export team:

Email: kurimoto@mate-osaka.co.jp
Tel: +81-72-665-5736

All exports are conducted through proper regulatory procedures including customs clearance, B/L or AWB documentation, and T/T advance payment. We do not engage in hand-carry, cash transactions, or sales to unlicensed parties.